Tali Gorfine Notifies Galmed Pharmaceuticals Ltd. to Reduce the Scope of Her Activities, Starting July 2020
May 21, 2020 at 04:33 pm EDT
On May 17, 2020, Dr. Tali Gorfine notified Galmed Pharmaceuticals Ltd. that due to personal
reasons she would need to reduce the scope of her activities, starting July 2020. This decision is not related
to operations of the Company. The Company initiated a search for a new Chief Medical Officer who would be based
in the United States, with a view to expanding the Company's presence in the United States. Dr. Gorfine
intends to support the transition period as required and continue to support the Company's clinical activities.